Yield10 Bioscience, Inc. (OTCPK: YTEN.Q)
Health Care · Biotechnology · US
$—
— today · — 1Y
Yield10 Bioscience, Inc. (OTCPK: YTEN.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $73.00 and employs 29 people.
trading between 0.00 and 0.00.
Tweenvest scores Yield10 Bioscience, Inc. across four factors: quality 3/100, value 48/100, growth 0/100. Its strongest factor is value.
YTEN.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $73.00
- Revenue (TTM)
- $750.00K
- P/E
- —
- EPS
- -24.93
- Dividend yield
- —
- Beta (5Y)
- 19.40
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 734.41K
- Employees
- 29
- Next earnings
- —
About Yield10 Bioscience, Inc.
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
- ISIN
- US98585K8541
- Founded
- 1992
- Listed since
- Nov 10, 2006
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.